• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The World Market for Liquid Biopsy, 2023

$6,000.00 – $12,000.00

Clear
SKU: 22-048 Categories: Biotechnology Market Research, Diagnostics Market Research, Emerging Technologies Market Reports, Liquid Biopsy, Next Generation Sequencing Tags: CTC-based Liquid Biopsy Market, ctDNA-based Liquid Biopsy Market, EV and Exosome-based Liquid Biopsy Market, Liquid Biopsy Market, Liquid Biopsy Market by Type of Cancer, Multi-Analyte-based Liquid Biopsy Market Pages: 211
  • Description
  • Table of Contents
  • Latest reports

Description

Dramatic changes have occurred in the liquid biopsy market, necessitating a resource to provide perspective on the market opportunity. This new report from Kalorama assesses the Liquid Biopsy Market now and in 2027.  The report can be useful for business planning, market share assessment, competitive research, and due diligence for mergers and acquisitions and other partnerships.

Liquid biopsy is gaining acceptance each year.  Even through the COVID-19 pandemic, announcements of new liquid biopsy products were made and studies conducted to assess the capability of these tests in clinical diagnostics uses.  While tissue biopsies and imaging techniques remain the current standards of care in the diagnosis of solid tumors, they have risks and limitations and limitations, some of which can be overcome by the use of liquid biopsy in clinical oncology, as an alternative or complementary technique to the current standards of care.

This report, The World Liquid Biopsy Market, 2023, from Kalorama Information, contains up-to-date information and useful data points for business planning:

The Market for Liquid Biopsy by Region

  • North America
  • Europe
  • Asia
  • Rest of World

The Market for CTC-based Liquid Biopsy

  • Growth to 2027

The Market for ctDNA-based Liquid Biopsy

  • Growth to 2027

The Market for EV and Exosome-based Liquid Biopsy

  • Growth to 2027

The Market for Multi-Analyte-based Liquid Biopsy

  • Growth to 2027

The Market for Other Analytes Liquid Biopsy

  • Growth to 2027

Liquid Biopsy Market by Type of Cancer

  • Breast
  • Lung
  • Colorectal
  • Ovarian
  • Prostate
  • Pan-Cancer
  • Other Cancer

R&D: Selected ctDNA-based Liquid Biopsy Tests in Development

On the Market: Selected Market-Available CTC-based Liquid Biopsy Tests, 2021

On the Market: Selected Liquid Biopsy Tests That Assess Multiple Analytes, 2021

Liquid biopsy testing has many potential applications in aspects of clinical oncology, including:

  • Early detection and diagnosis / screening
  • Alternative testing method when tissue biopsy is difficult/impossible, or when the primary site of metastatic disease is unknown
  • Therapy personalization and monitoring – by molecular characterization of a patient’s disease, clinicians can select the optimal course of therapy and monitor efficacy over time, as well as quickly react to adjust therapy should treatment resistance arise
  • Disease monitoring – to observe disease progression, tumor evolution, residual disease, and early detection of recurrence

These applications, increasing acceptance, the use of liquid biopsy in combination with other technologies.   This report contains market assessments for these application categories.

In addition, the report profiles key companies in the market, including:

  • Adaptive Biotechnologies
  • Agena Bioscience, Inc.
  • Angle, PLC
  • Aspira Women’s Health
  • Biocartis Group Nv
  • Biocept, Inc.
  • Biodesix
  • Cellmax Life
  • Circulogene
  • Diacarta, Inc.
  • Epic Sciences
  • Epigenomics AG
  • Exact Sciences
  • Exosome Diagnostics, Inc.
  • Foundation Medicine, Inc. (Roche)
  • Freenome, Inc.
  • Gilupi Gmbh
  • Grail (Illumina)
  • Guardant Health, Inc.
  • Hologic
  • Lunglife AI (Formerly Cynvenio Biosystems)
  • Menarini-Silicon Biosystems, SPA
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • Neogenomics Laboratories, Inc.
  • Oncocyte Corporation
  • Oncodna S.A.
  • Personal Genome Diagnostics
  • Qiagen N.V.
  • Cell-Free DNA Technologies
  • Ctc Technologies
  • Exosome And Mirna Technologies
  • Resolution Biosciences (Agilent)
  • Roche Diagnostics
  • Sysmex-Inostics, Inc.
  • Tempus
  • Volitionrx

Table of Contents

Chapter One: Executive Summary

Introduction

Liquid Biopsy Technologies

Industry Structure

Liquid Biopsy Market Revenues and Forecast

  • Figure 1-1: Market for Liquid Biopsy 2022-2027
  • Figure 1-2: Global Liquid Biopsy Market by Geographic Region, 2022 (%)
  • Table 1-1:  Global Liquid Biopsy Market by Geographic Region, 2022-2027 $(M)

 

Chapter Two: Liquid Biopsy Technologies

Introduction

  • Table 2-1: Comparison of Tissue and Liquid Biopsy

Current Major Liquid Biopsy Technologies

  • Table 2-2: Advantages and Limitations of Major Liquid Biopsy Technologies

 

Chapter Three: Circulating Tumor DNA (ctDNA) Liquid Biopsy

Introduction

Advantages and Limitations of ctDNA in Liquid Biopsy

Current ctDNA-based Liquid Biopsy Tests

  • Table 3-1: Selected Market-Available ctDNA-based Liquid Biopsy Tests, 2022Company/ Country

Biocartis

Biocept

Biodesix

CellMax Life

Circulogene

Diacarta

Epigenomics

Foundation Medicine (Roche)

Guardant Health

Inivata (Neogenomics)

LungLife AI

Myriad Genetics

NeoGenomics

OncoDNA

Personal Genomic Diagnostics

QIAGEN

Resolution Biosciences

Roche Diagnostics

Sysmex-Inostics

Tempus

ctDNA-based Liquid Biopsy Tests in Development

  • Table 3-2: Selected ctDNA-based Liquid Biopsy Tests in Development, 2022

Exact Sciences

Freenome

GRAIL

 

Chapter Four: Circulating Tumor Cells (CTCs) Liquid Biopsy

Introduction

Challenges in the Development of CTC-based Liquid Biopsy Tests

CTC-based Liquid Biopsy Tests

  • Table 4-1: Selected Market-Available CTC-based Liquid Biopsy Tests, 2022

Adaptive Biotechnologies

ANGLE

Biocept

CellMax Life

Epic Sciences

GILUPI

LungLife AI

Menarini-Silicon Biosystems

QIAGEN

Selected CTC-based Liquid Biopsy Tests in Development

  • Table 4-2: Selected CTC-based Liquid Biopsy Tests in Development, 2022

Epic Sciences

Liquid Biotech USA

 

Chapter Five: Extracellular Vesicles and Other Liquid Biopsy

Introduction

Liquid Biopsy Tests Based on Extracellular Vesicles / Other Analytes

  • Table 5-1: Selected Market-Available Liquid Biopsy Tests based on Extracellular Vesicles / Other Analytes, 2022

Aspira Women’s Health (formerly Vermillion)

Biodesix

Exosome Diagnostics

Hologic

MDxHealth

Extracellular Vesicle/Other Analyte-based Liquid Biopsy Tests in Development

  • Table 5-2: Selected Extracellular Vesicle/Other Analyte-based Liquid Biopsy Tests in Development, 2022

Circulogene

OncoCyte

Resolution Biosciences

VolitionRx

 

Chapter Six: Multi-Analyte Liquid Biopsy Tests

Introduction

Liquid Biopsy Tests Based on Multiple Analytes

  • Table 6-1: Selected Liquid Biopsy Tests That Assess Multiple Analytes, 2022

Biocept

Biodesix

Foundation Medicine (Roche)

LungLife AI

NeoGenomics

OncoDNA

Multiple Analyte-based Liquid Biopsy Tests in Development

  • Table 6-2: Selected Multi Analyte-based Liquid Biopsy Tests in Development, 2022

Exact Sciences

Freenome

GRAIL

LungLife AI

 

Chapter Seven: Liquid Biopsy Tests for Research Use Only

Introduction

Liquid Biopsy Tests for Research Use Only

  • Table 7-1: Selected Liquid Biopsy Tests for Research Use Only, 2022

Agena Bioscience

DiaCarta

Exosome Diagnostics

Guardant Health

Natera

QIAGEN

 

Chapter Eight: Liquid Biopsy Industry Analysis

Introduction

Tiers of Competition

  • Table 8-1: Selected Participants in the Liquid Biopsy Market, 2022

Competitive Factors

Significant Market Trends

  • Table 8-2: Significant Trends in the Liquid Biopsy Market, 2022

Personalized Medicine

Increasing Global Life Expectancy

New Liquid Biopsy Products

Increasing Accessibility of Genetic Testing

Regulatory Hurdles

Third-Party Payor Coverage

Demonstrated Clinical Utility

Incidence Rates of Specific Cancers

Competitors No Longer in the Liquid Biopsy Market

  • Table 8-3: Summary of Companies That Have Exited the Liquid Biopsy Market

 

Chapter Nine: Liquid Biopsy Market

Market Overview

  • Table 9-1: Global Liquid Biopsy Diagnostics Market Estimate by Region, 2022 (%)
  • Figure 9-1: Global Liquid Biopsy Diagnostics Market Estimate by Region, 2022 (%)

Market Forecast

  • Table 9-2: Global Liquid Biopsy Market Forecast by Region – North America, Europe, Asia Pacific, Rest of World, World ($ millions), 2022-2027

 

Chapter Ten: Market by Analyte

Circulating Tumor DNA

Market Overview

Applications

Technologies

Specimens

Revenue Forecast

  • Table 10-1: Global Liquid Biopsy Market for ctDNA ($ millions), 2022-2027

Circulating Tumor Cells

Market Overview

Applications

Technologies

Specimens

Revenue Forecast

  • Table 10-2: Global Liquid Biopsy Market for CTCs ($ millions), 2022-2027

Extracellular Vesicles and Other Analytes

Market Overview

Applications

Technologies

Specimens

Revenue Forecast

  • Table 10-3: Global Liquid Biopsy Market for Extracellular Vesicles ($ millions), 2022-2027

Multiple Analytes

Market Overview

Revenue Forecast

  • Table 10-4: Global Liquid Biopsy Market for Multiple Analytes ($ millions), 2022-2027

 

Chapter Eleven: Market by Application

Therapy Guidance and Monitoring

Market Overview

Revenue Forecast

  • Table 11-1: Liquid Therapy for Therapy Guidance ($ millions), 2022-2027

Diagnosis/Screening

Market Overview

Revenue Forecast

  • Table 11-2: Global Liquid Biopsy Market for Diagnosis and Screening ($ millions), 2022-2027

Disease Prognosis

Market Overview

Revenue Forecast

  • Table 11-3: Global Liquid Biopsy Market for Disease Prognosis ($ millions), 2022-2027

 

Chapter Twelve: Market by Cancer Type

Breast Cancer

Market Overview

Revenue Forecast

  • Table 12-1: Global Liquid Biopsy Market for Breast Cancer ($ millions), 2022-2027

Colorectal Cancer

Market Overview

Revenue Forecast

  • Table 12-2: Global Liquid Biopsy Market for Colorectal Cancer ($ millions), 2022-2027

Lung Cancer

Market Overview

Revenue Forecast

  • Table 12-3: Global Liquid Biopsy Market for Lung Cancer ($ millions), 2022-2027

Ovarian Cancer

Market Overview

Revenue Forecast

  • Table 12-4: Global Liquid Biopsy Market for Ovarian Cancer ($ millions), 2022-2027

Prostate Cancer

Market Overview

Revenue Forecast

  • Table 12-5: Global Liquid Biopsy Market for Prostate Cancer ($ millions), 2022-2027

Other Cancers

Market Overview

Revenue Forecast

  • Table 12-6: Global Liquid Biopsy Market for Other Cancers ($ millions), 2022-2027

Pan-Cancer Tests

Market Overview

Revenue Forecast

  • Table 12-7: Global Liquid Biopsy Market for Pan-Cancer Testing ($ millions), 2022-2027

 

Chapter Thirteen: Company Profiles

Companies in the Market

  • Table 13-1 Companies in the Liquid Biopsy Market

Adaptive Biotechnologies

Agena Bioscience, Inc.

ANGLE, plc

Aspira Women’s Health

Biocartis Group NV

Biocept, Inc.

Biodesix

CellMax Life

Circulogene

DiaCarta, Inc.

Epic Sciences

Epigenomics AG

Exact Sciences

Exosome Diagnostics, Inc.

Foundation Medicine, Inc. (Roche)

Freenome, Inc.

GILUPI GmbH

GRAIL (Illumina)

Guardant Health, Inc.

Hologic

LungLife AI (formerly Cynvenio Biosystems)

Menarini-Silicon Biosystems, Spa

Myriad Genetics, Inc.

Natera, Inc.

NeoGenomics Laboratories, Inc.

Oncocyte Corporation

OncoDNA S.A.

Personal Genome Diagnostics

QIAGEN N.V.

Cell-free DNA Technologies

CTC Technologies

Exosome and miRNA Technologies

Resolution Biosciences (Agilent)

Roche Diagnostics

Sysmex-Inostics, Inc.

Tempus

VolitionRx

    The Worldwide Market for Mass Spectrometry in Clinical Labs, 2024
    September 11, 2024
    Worldwide Sequencer Market, 2023-2028
    August 8, 2024
    The Worldwide Market for Liquid Biopsy, 6th Edition
    December 29, 2023
    The Market for RNA Sequencing, 3rd Edition
    September 8, 2023

Related products

  • Placeholder image

    Liquid Chromatography Markets (LC, HPLC and UHPLC)

    $1,995.00 – $3,990.00
  • Placeholder image

    Gene Expression Profiling Markets

    $995.00 – $7,990.00
  • Placeholder image

    Stem Cells – Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development

    $995.00 – $7,800.00
  • Placeholder image

    Stem Cell Therapeutics Markets

    $995.00 – $5,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
IVD Trends and Market Update: November 2022 Physician Office In Vitro Diagnostic (IVD) Test Markets
Scroll to top